Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
John M. Leonard currently holds 467,352 shares of Intellia Therapeutics, Inc. (NTLA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John M. Leonard has been a net seller of NTLA stock. They have purchased $163.4K and sold $6.6M worth of shares.
John M. Leonard's most recent insider trade was on Sep 1, 2020, when they sold 5,000 shares at $21.83 per share.
John M. Leonard serves as Executive at Intellia Therapeutics, Inc. (NTLA). They have executed 35 insider transactions totaling $6.8M over their tenure at the company.
John M. Leonard holds the position of Executive at Intellia Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 13 years and currently hold a stake valued at $0.
John M. Leonard has shown a selling trading pattern, with $163.4K in total purchases and $6.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by John M. Leonard was on Mar 15, 2013, when they sold $1.8M worth of ABBV shares. This transaction involved 46,700 shares at $38.45 per share.
John M. Leonard currently owns 467,352 shares of Intellia Therapeutics, Inc. (NTLA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of John M. Leonard's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. John M. Leonard has 35 Form 4 filings on record as an insider at Intellia Therapeutics, Inc..
Set alerts for John M. Leonard and 40,000+ other insiders.